In 2020, Vifor Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 3 (indirect emissions across the value chain).
Vifor Pharma has also provided a category-level breakdown for 3 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2020 | 2019 |
|---|---|---|
Total Scope 1 | N/A | N/A |
Total Scope 2 | ||
Market-Based | N/A | N/A |
Location-Based | N/A | N/A |
Total Scope 3 | 6,771a | 10,653a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
No operational GHG emissions data disclosed for Vifor Pharma in 2020.
NaNIn 2020, Vifor Pharma reported 6,771 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2020 disclosure of Vifor Pharma includes a breakdown across 3 of the 15 Scope 3 categories defined by the GHG Protocol, up from 2 in 2019, reflecting improved emissions accounting practices and greater transparency across the company's value chaina
In 2020, Vifor Pharma reported total Scope 3 emissions of 6,771 metric tons of CO₂ equivalent (tCO₂e).a
Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment.a
Compared to the previous year (2019), Vifor Pharma's Scope 3 emissions decreased by 36.44%, highlighting the company's efforts to lower indirect emissions from its value chain.a
In 2020, Vifor Pharma reported emissions for 3 out of the 15 Scope 3 categories defined by the GHG Protocol.a
The limited disclosure restricts visibility into specific emission sources across the company's value chain.
In 2020, the largest contributors to Vifor Pharma's Scope 3 emissions were:a